Log In
Print this Print this

Glycooptimized TrastuzuMab-GEX, TrasGEX (GT-Mab 7.3-GEX)

  Manage Alerts
Collapse Summary General Information
Company Glycotope GmbH
DescriptionGlycooptimized version of trastuzumab, a humanized mAb against epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today